Histologic Characteristics Enhance Predictive Value of American Joint Committee on Cancer Staging in Resectable Pancreas Cancer
|
|
- Denis Paul
- 5 years ago
- Views:
Transcription
1 Original Article Histologic Characteristics Enhance Predictive Value of American Joint Committee on Cancer Staging in Resectable Pancreas Cancer James Helm, MD, PhD 1,2,3,4,5 ; Barbara A. Centeno, MD 3,6,7 ; Domenico Coppola, MD 3,6,7 ; Marcovalerio Melis, MD 1,3,8 ; Mark Lloyd, BS 9 ; Jong Y. Park, PhD 2,3 ; Dung-Tsa Chen, PhD 3,10 ; and Mokenge P. Malafa, MD 1,3,8 BACKGROUND: American Joint Committee on Cancer (AJCC) anatomic stage group is considered relatively nondiscriminatory for predicting differences in survival after pancreatectomy for ductal adenocarcinoma, a perception confirmed in the authors patients and by other reports. The authors aim was to investigate the potential for improving the predictive value of AJCC staging by incorporating individually predictive histologic features into AJCC tumor-node-metastasis classification of anatomic extent, and determine the simplest combination of tumor characteristics predicting survival. METHODS: The authors determined survival of 137 patients who underwent pancreatectomy for ductal adenocarcinoma with curative intent (stage Groups IA - IIB) at Moffitt Cancer Center during the last 2 decades using data obtained from medical record review, the Moffitt Cancer Registry, and the Social Security Death Index. Histologic characteristics were confirmed by expert review. RESULTS: Median survival was 21.2 months after pancreatectomy with a 3-year disease-specific survival of 36%. Univariate Kaplan-Meier analysis and multivariate Cox proportional hazard modeling found worse survival with local extrapancreatic extension, poorly differentiated histology, and lymphatic invasion within tumor (P <.05). Survival was not worse with nodal metastases, microscopically positive resection margins, and perineural or venous invasion, nor was survival better with cancer arising from an intraductal papillary mucinous neoplasm. Kaplan-Meier estimates for different variable combinations showed prognosis was best for well- or moderately differentiated tumors without lymphatic invasion and confined to the pancreas (9.9 years median survival), worst for poorly differentiated tumors with lymphatic invasion and local extension beyond the pancreas (8.5 months median survival), and intermediate for well- or moderately differentiated tumors with either lymphatic invasion or local extension beyond the pancreas (21.2 months median survival). CONCLUSIONS: A simple combination of tumor differentiation, lymphatic invasion within the tumor, and local extrapancreatic extension predicts survival after pancreatectomy for ductal adenocarcinoma. Cancer 2009;115: VC 2009 American Cancer Society. KEY WORDS: pancreas, cancer, survival, stage, prediction, histology. Corresponding author: James Helm, MD, PhD, and Mokenge P. Malafa, MD, Moffitt Cancer Center, Tampa, Florida; Fax: (813) ; james. helm@moffitt.org or mokenge.malafa@moffitt.org 1 Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, Florida; 2 Department of Cancer Epidemiology and Genetics, Moffitt Cancer Center, Tampa, Florida; 3 Department of Oncologic Sciences, University of South Florida, Tampa, Florida; 4 Department of Surgery, University of South Florida, Tampa, Florida; 5 Department of Pathology, University of South Florida, Tampa, Florida; 6 Department of Pathology, Moffitt Cancer Center, Tampa, Florida; 7 Department of Biostatistics, Moffitt Cancer Center, Tampa, Florida; 8 Department of Research Administration, Moffitt Cancer Center, Tampa, Florida; 9 Department of Medicine, University of South Florida, Tampa, Florida; 10 Department of Epidemiology, University of South Florida, Tampa, Florida Appreciation is expressed to Debi Mote, BBA, for assistance in development of the study database. Received: December 10, 2008; Revised: February 6, 2009; Accepted: February 24, 2009 Published online July 22, 2009 in Wiley InterScience ( DOI: /cncr.24503, Cancer September 15, 2009
2 Survival After Pancreatectomy for Cancer/Helm et al More than 37,000 new cases of pancreatic cancer are expected in the US in 2008, with the great majority of these being ductal adenocarcinomas. 1 No greater than 5% of all pancreatic cancer patients will survive 5 years, the lowest long-term survival rate of any cancer. The only real chance of long-term survival with pancreatic adenocarcinoma belongs to those patients with localized disease in whom a potentially curative resection can be performed. Yet even among patients who undergo pancreatectomy with curative intent, the outcome is highly variable, with survival ranging from a matter of months to many years. 2 The practice of classifying various kinds of cancers by stage arose from the observation that survival was better in patients with early localized cancers than for late cancers extending beyond the organ of origin. The American Joint Committee on Cancer (AJCC) tumor-nodemetastasis (TNM) classification system is based on the premise that cancers with the same anatomic extent and histology will share similar behaviors and outcomes. 3 In the AJCC system, tumors are classified by 3 significant events in the life history of a cancer: local tumor growth (T), spread to regional lymph nodes (N), and distant metastases (M). T, N, and M classifications are combined into stage groups intended to describe the anatomic extent of the cancer in a way related to its natural history. However, AJCC anatomic stage group (IA, IB, IIA, IIB) is considered relatively nondiscriminatory for predicting differences in survival among patients who have undergone pancreatectomy for resectable ductal adenocarcinoma, 4,5 a perception confirmed by analysis of outcomes in our patients and the work of others. 6 For pancreatic adenocarcinoma, as for most other cancers, AJCC staging is concerned with only the anatomic extent of the disease. 3 However, the AJCC does recognize that histologic characteristics of a tumor may be significant determinants of prognosis in some cancers, such as the histologic grade in soft-tissue sarcoma. Various histopathologic characteristics have been reported to be individually predictive of survival after pancreatectomy for ductal adenocarcinoma Our aim in this study was to incorporate individually predictive histologic characteristics into the present TNM system of classification by anatomic extent and determine the simplest combination of these features that is predictive of survival after pancreatectomy for ductal adenocarcinoma. MATERIALS AND METHODS We previously reported our experience with 238 patients who underwent pancreatic resection for a primary cancer or premalignant neoplasm at the H. Lee Moffitt Cancer Center and Research Institute from January, 1987 through December, The current study is focused on the 137 patients with stage IA-IIB ductal pancreatic cancer who survived at least 30 days following pancreatectomy with curative intent. At least 61 patients received adjuvant chemotherapy, radiation therapy, or both, while no one underwent neoadjuvant therapy. Patients were identified by searching surgical and pathology administrative databases, as well as the Moffitt Cancer Registry. A pathologist with expertise in pancreatic cancer (BAC) confirmed the histologic diagnosis by review of stained sections cut from fixed surgical specimens. The World Health Organization International Classification of Diseases for Oncology, third edition (ICD-O-3), 22 was used to classify pancreatic neoplasms based on the dominant histologic appearance. Data from the Moffitt Cancer Registry, the patient s medical record, and the Social Security Death Index were reviewed to determine the patient s clinicopathologic characteristics, tumor stage, survival of each patient following surgery, whether the patient was deceased as of most recent knowledge, and if there was evidence of disease at that time. Disease stage for all patients was defined by the present-day TNM classification of the AJCC Cancer Staging Manual, sixth edition. 3 This study was approved by the Institutional Review Board of the University of South Florida, Tampa. Statistical Analysis Disease-specific survival was estimated by the Kaplan- Meier method, using death with evidence of disease as the endpoint. Median survival, as well as 1-, 2-, 3-, and 5-year probabilities of survival, were determined. The log-rank test for equality of survival functions was used to compare Kaplan-Meier survival curves. Multivariate Cox proportional hazards modeling was used to determine the hazard of death with evidence of disease posed by a given variable, at any given time after surgery, adjusting for all other covariates. Global and covariate-specific tests based on both residuals and on graphical methods showed no evidence for violation of the proportional hazards Cancer September 15,
3 Original Article Table 1. AJCC Staging by Anatomic Extent in 137 Patients Who Underwent Resection of Pancreatic Adenocarcinoma and Survived at Least 30 Days After Surgery No. (%) FIGURE 1. Kaplan-Meier survival estimate for 137 patients who underwent resection of stage IA-IIB invasive ductal pancreatic cancer and survived at least 30 days after surgery. Surgeries were done at the H. Lee Moffitt Cancer Center and Research Institute during the 20-year period of 1987 through assumption in all instances. Proportions were compared by the chi-squared test. RESULTS The Kaplan-Meier disease-specific survival estimate for all 137 patients who underwent resection of stage IA-IIB ductal pancreatic cancer and survived at least 30 days after surgery is shown in Figure 1. Median survival was 21.2 months after resection, with the longest survival known to be 15.7 years without evidence of disease. The probabilities of surviving 1 year, 2 years, 3 years, and 5 years after resection were 0.70 (95% CI, 0.61, 0.78), 0.42 (95% CI, 0.32, 0.51), 0.36 (95% CI, 0.26, 0.46), and 0.32 (95% CI, 0.22, 043), respectively. Table 1 shows the AJCC stage group, and T, N, and R classifications for all 137 patients who underwent pancreatectomy. The Kaplan-Meier survival estimates corresponding to each stage group are shown in Figure 2. The 3 survival curves representing the 128 patients with stages IB, IIA, and IIB cancers did not differ significantly from each other (P ¼.26). Survival for stage Group IA, which included only 9 patients, was significantly greater than the other stage groups taken together (P <.05). Median survival for stage IA was 9.85 years after resection, as compared with median survivals of 1.94 years, 1.57 years, and 1.43 years for stage Groups IB, IIA, and IIB, respectively. Univariate Kaplan-Meier survival curves for T, N, and R classifications are shown in Figure 3A, 3B, and 3C, Stage group IA tumor 2 cm, confined to pancreas, 9 (7) no positive nodes IB tumor >2 cm, confined to pancreas, 21 (15) no positive nodes IIA local extrapancreatic extension without 44 (32) celiac axis or SMA involvement, no positive nodes IIB regional node metastasis 63 (46) T classification T1 tumor 2 cm, confined to pancreas 14 (10) T2 tumor >2cm, confined to pancreas 28 (20) T3 local extrapancreatic extension without 95 (70) celiac axis or superior mesenteric artery involvement N classification N0 no nodal metastases 72 (53) N1 regional node metastases 65 (47) R classification R0 negative resection margin 100 (73) R1 microscopically positive resection margin 37 (27) FIGURE 2. Kaplan-Meier survival estimate by stage group for 137 patients who underwent resection of stage IA-IIB invasive ductal pancreatic cancer and survived at least 30 days after surgery. Survival for stage Group IA was significantly greater than the other stage groups, collectively (P <.05). Survival for stage Groups IB, IIA, and IIB did not differ significantly from each other (P ¼.26). while the corresponding numbers of patients staged are given in Table 1. Differences in tumor size (T2 vs T1) did not affect survival as long as the tumor was confined to the pancreas (P ¼.28). Local extrapancreatic extension of the cancer without celiac axis or superior mesenteric artery involvement (T3), however, was associated with 4082 Cancer September 15, 2009
4 Survival After Pancreatectomy for Cancer/Helm et al FIGURE 3. Kaplan-Meier survival estimate by T, N, and R classifications, and cancer origin, for 137 patients who underwent resection of stage IA-IIB ductal pancreatic cancer. (A) Survival for those patients with a cancer confined to the pancreas but >2 cm (T2) was not significantly worse than with a cancer 2 cm (T1); however, local extension beyond the pancreas (T3) significantly worsened survival compared with cancers of any size confined to the pancreas (T1 or T2; P <.05). (B and C) Neither regional nodal metastases (N1) nor microscopic cancer at the resection margin (R1) significantly worsened prognosis, and (D) survival was not significantly better if the cancer originated from an intraductal papillary mucinous neoplasm. significantly worse survival compared with cancers of any size confined to the pancreas (P <.05). Survival in patients with regional nodal metastases (N1) fell short of being significantly worse than in patients who did not have nodal metastases (P ¼.15). Finding microscopic evidence of cancer at any resection margin (R1) was not associated with a significantly worse prognosis (P ¼.51). Univariate Kaplan-Meier survival estimates for different histologic characteristics are shown in Figures 3D and 4, while the corresponding numbers of patients described by these curves are given in Table 2. Origination of invasive ductal adenocarcinoma from an intraductal papillary mucinous neoplasm (IPMN) was not associated with significantly better survival (P ¼.54). Survival curves for patients with moderately differentiated and well-differentiated cancers did not differ significantly (P ¼.47). Poorly differentiated histology, however, was associated with significantly worse survival compared with more differentiated histology (P <.05). Lymphatic invasion within the tumor was associated with a worse survival (P <.05), although as we have already noted, the presence of regional lymph node metastases fell short of being associated with a significantly worse prognosis. About 69% of patients with lymphatic invasion within the tumor had regional lymph node metastases, but in the absence of lymphatic invasion, only 7.5% of patients had lymph node metastases (P <.05). Thus, lymphatic invasion within the tumor appears to precede regional lymph node metastasis. Cancer September 15,
5 Original Article FIGURE 4. Kaplan-Meier survival estimates by histologic characteristic for 137 patients who underwent resection of stage IA-IIB ductal pancreatic cancer. (A) Survival for patients with a moderately differentiated cancer did not differ from those with a welldifferentiated tumor; however, survival was significantly worse with poor differentiation (P <.05). (B) Survival was worse if lymphatic invasion was present within the tumor (P <.05). (C and D) Neither venous invasion nor perineural invasion within the tumor affected survival significantly. Venous or perineural invasion within the tumor did not affect survival significantly (P ¼.44 and 0.47, respectively). We used a multivariate Cox proportional hazard model to identify which histopathological variables individually predicted a worse survival when adjusted for all other covariates (Table 3). For this analysis, we combined all patients with a tumor of any size confined to the pancreas into 1 group (T1 and T2) because the survival curves for T1 and T2 were not significantly different. For similar reasons, we combined patients with well- or moderately differentiated tumors into 1 group. The multivariate Cox proportional hazard model identified local extrapancreatic extension (T3), poorly differentiated histology, and lymphatic invasion within the tumor as being the only significant predictors of worse survival, adjusting for other covariates. These variables are the same ones identified by the univariate Kaplan-Meier estimates as having predictive value. The hazard ratios indicate that death with evidence of disease is about 1.5 to 3.0 times as likely at any given time after surgery if any 1 of these 3 predictors alone is present. We next determined Kaplan-Meier survival estimates for different combinations of the 3 histopathologic characteristics that were identified by both univariate survival analysis and multivariate Cox modeling as being individually prognostic for survival. Only 115 of the 137 patients had information available for all 3 prognostic characteristics, and the distribution of these patients among the 8 possible combinations of characteristics is shown in Table 4. The majority of patients with poorly differentiated tumors had local invasion beyond the 4084 Cancer September 15, 2009
6 Survival After Pancreatectomy for Cancer/Helm et al Table 2. Histologic Characteristics in 137 Patients Who Underwent Resection of Pancreatic Adenocarcinoma and Survived at Least 30 Days After Surgery No. (%) Tumor arose from IPMN No 53 (52) Yes 48 (48) Histologic differentiation Well 33 (24) Moderate 76 (56) Poor 26 (19) Lymphatic invasion Absent 40 (34) Present 77 (66) Venous invasion Absent 70 (64) Present 39 (36) Perineural invasion Absent 22 (17) Present 106 (83) IPMN indicates intraductal papillary mucinous neoplasm. Total number of patients for each characteristic does not equal 137 because not all patients had a complete set of observations; one undifferentiated cancer was grouped with the poorly differentiated tumors. pancreas, as well as histologic evidence of lymphatic invasion within the tumor (Group 8). Median survival in this group of 13 patients was 8.5 months, with 1- and 2-year survival probabilities of 34% and 23%, and none known to live more than 27 months. Individual survival curves were not determined for combination Groups 5, 6, and 7, because the number of patients in each of these groups would be too small for the curves to be meaningful. Instead, we pooled the outcomes of all patients with poorly differentiated tumors, including 4 such patients in whom all 3 prognostic characteristics were not available, and the result is a single survival curve representing the outcome in a total of 26 patients with poorly differentiated tumors (Fig. 5). The outcomes of patients in Groups 2 and 3 were likewise pooled and a single survival curve determined, because the individual survival curves for Groups 2 and 3 were found to overlie each other and did not differ significantly (P ¼.37). Figure 5 shows that the prognosis became increasingly worse as the histopathologic characteristics of the tumor became reflective of a more aggressive tumor biology. Survival was significantly better for well- or moderately differentiated tumors confined to the pancreas and without histologic lymphatic invasion (Group 1), as compared Table 3. Results of Cox Proportional Hazards Multivariable Model That Includes all Histopathologic Characteristics Potentially Predictive of Survival in the 78 Patients Who Had a Complete Set of Observations for all Characteristics Histopathologic Characteristic T classification T1 or T2 tumor confined to pancreas T3 Local extrapancreatic extension without celiac axis or SMA involvement Hazard Ratio (95% CI) with patients in other groups (P <.05). Survival was the worst for poorly differentiated tumors as compared with either the least histologically aggressive tumors (Group 1) or the intermediate group of patients with well- or moderately differentiated tumors who had either local invasion beyond the pancreas or lymphatic invasion (pooled Groups 2 and 3; P <.05). Interestingly, the survival curve for patients with moderately or well-differentiated tumors, local invasion beyond the pancreas, and lymphatic invasion (Group 4) was not significantly different from either the survival curve for poorly differentiated tumors (P ¼.27) or the curve for pooled Groups 2 and 3 (P ¼.29). Inspection of the survival curves of Figure 5 P 1.53 ( ).04 N classification N0 no nodal metastases N1 regional node metastases.75 ( ).57 R classification R0 negative resection margin R1 microscopically positive resection margin 1.08 ( ).86 Tumor arose from IPMN No Yes.86 ( ).69 Histologic grade Well or moderately differentiated Poorly differentiated 1.88 ( ).003 Lymphatic invasion Absent Present 3.03 ( ).03 Venous invasion Absent Present.90 ( ).80 Perineural invasion Absent Present.55 ( ).25 IPMN indicates intraductal papillary mucinous neoplasm. Cancer September 15,
7 Original Article Table 4. Possible Combinations of Histopathologic Characteristics Predictive of Survival in the 115 Patients Who Had a Complete Set of Observations on all Three Characteristics Group Histologic Differentiation Local Invasion Beyond Pancreas Lymphatic Invasion No. 1 Moderate or well No No 15 2 Moderate or well Yes No 19 3 Moderate or well No Yes 14 4 Moderate or well Yes Yes 45 5 Poor No No 1 6 Poor Yes No 4 7 Poor No Yes 4 8 Poor Yes Yes 13 suggests that initially the Group 4 patients will have a poor prognosis similar to that of patients who have a poorly differentiated tumor, but after 1 year, the prognosis improves and the survival curve comes to overlie the curve for pooled Groups 2 and 3. Median survival and probability of survival at 1 year, 2 years, 3 years, and 5 years are shown for different combinations of histopathologic characteristics in Table 5. FIGURE 5. Kaplan-Meier survival estimates for different combinations of the histopathologic characteristics that were found to be prognostic for survival in 119 patients who underwent resection of stage IA-IIB ductal pancreatic cancer. Prognosis was increasingly worse as histopathologic characteristics became reflective of a more aggressive tumor biology. DISCUSSION AJCC TNM classification is used inconsistently for staging ductal adenocarcinoma of the pancreas, perhaps, in large part, because the prognosis of the disease is generally poor, with no >20% of patients being candidates for potentially curative surgery. 11,23 Resectable cancers are classified into group stages IA through IIB; however, AJCC staging does not adequately reflect the heterogeneity in outcomes among patients who undergo pancreatectomy. We confirmed the perception that AJCC anatomic staging is relatively nondiscriminatory for predicting differences in survival among patients who undergo pancreatectomy for resectable ductal pancreatic cancer. 4,5 We found that AJCC anatomic stage groups did not predict differences in survival among the stage IB, IIA, and IIB patients who accounted for 93% of our patients who underwent resection of pancreatic cancer with curative intent. Predictably, better survival was found in only the small number of patients with early stage IA cancers, that is, those less than 2 cm in size and confined to the pancreas without regional lymph node metastases. We sought to improve upon AJCC anatomic staging by incorporating potentially predictive histologic characteristics into the TNM classification, an approach consistent with the AJCC s recognition that histologic features may be important determinants of prognosis in some cancers. 3 In doing so, our goal was to separate patients into groups predictive of survival after pancreatectomy. The first step in our analytic strategy was to use Kaplan-Meier survival estimates to identify individually predictive histopathologic characteristics. Then Cox proportional hazards modeling was used to confirm which of these characteristics were predictive of survival after adjusting for confounding. Finally, Kaplan-Meier survival curves were determined for the different possible combinations of individually predictive histopathologic characteristics to separate patients into groups predictive of survival Cancer September 15, 2009
8 Survival After Pancreatectomy for Cancer/Helm et al Table 5. Kaplan-Meier Estimates of Survival for Different Combinations of Histopathologic Characteristics in 119 Patients Who Underwent Resection of Stage IA-IIB Ductal Pancreatic Cancer Probability of Surviving No. Median Survival, y 1 Year 2 Years 3 Years 5 Years Group Moderate or well differentiated Confined to pancreas, any size No lymphatic invasion Groups 2 and 3 combined Moderate or well differentiated Invasion beyond pancreas or lymphatic invasion Group Moderate or well differentiated Invasion beyond pancreas Lymphatic invasion Group Poor Poorly differentiated May or may not have invasion beyond pancreas or lymphatic invasion To determine which histopathologic characteristics we should test for being individually predictive of survival after pancreatectomy, we considered several factors to be important. First, an experienced pathologist should easily and reproducibly determine a predictive histopathologic characteristic. Furthermore, we believed that there should be a biologic rationale by which the characteristic might be expected to influence survival. Finally, we considered characteristics previously studied and the outcomes of these studies as reported in the literature. Although various histopathologic characteristics have been reported to be individually predictive of survival after pancreatectomy, not all studies are in agreement Why this should be true is not entirely clear; however, the reasons in some cases may be as simple as the observation that not all studies evaluated the same characteristics or that characteristics were defined differently between studies. We found, as did at least some of the other studies, that poor tumor differentiation, histologic evidence of lymphatic invasion within the tumor, and local extrapancreatic invasion were individually predictive of a worse survival Determining Kaplan-Meier survival estimates for the different possible combinations of the 3 individually predictive histopathologic characteristics allowed us to separate patients into groups predictive of survival after pancreatectomy. We were able to identify 4 groups of patients with distinctly different survival curves based on the histopathologic characteristics of their tumors. The observation that prognosis worsened as histopathologic characteristics reflected a more aggressive tumor biology lends credibility to our method and supports the validity of our findings. Of interest is the group of patients whose prognosis was initially similar to that of patients who had poorly differentiated tumors with the worst survival, but beyond a year, the survival curve came to overlie that of the patient group with an intermediate prognosis. The unique shape of the curve suggests that this group could be comprised of 2 groups of patients with different prognoses, although we do not have a more complete explanation. We are not the first to use a combination of histopathologic characteristics to predict survival after pancreatectomy for adenocarcinoma. Taking an analytical approach similar to our own, a study from Japan used univariate Kaplan-Meier survival estimates to identify characteristics that were individually predictive of survival after pancreatectomy from among 20 largely histopathologic variables. 18 Then Cox proportional hazard modeling was used to confirm that characteristics identified as being significant in the univariate analysis were significant predictors of survival in a multivariate analysis. The 4 characteristics found to be predictive of worsened survival Cancer September 15,
9 Original Article were tumor size greater than 3 cm, the presence of tumor necrosis, and high semiquantitative scores for intrapancreatic neural and lymphatic invasion. Although lymphatic invasion was found to have predictive significance, regional lymph node metastasis did not, an observation in agreement with our results. Histologic differentiation was predictive only of disease-free survival in the univariate analysis in this study, whereas we found that poor differentiation was the dominant predictor of poor survival. It is at this point that the investigators approach to analysis differed from ours, as they attempted to establish a predictive histologic classification based on how many of the 4 predictive characteristics were present. This scoring system assumes that each histologic characteristic is of equal predictive value, which is not necessarily the case. Kaplan- Meier survival curves stratified by number of predictive characteristics present showed that as the number increased, survival worsened progressively. In another study by Brennan and colleagues, the goal was to determine the best estimate of survival for any given patient based on that individual patient s own clinicopathologic characteristics, rather than to classify patients into groups that could be expected to have similar prognoses. 4 In summarizing what we know about predicting survival after pancreatectomy for ductal adenocarcinoma, we begin with our confirmation of the perception that AJCC staging based on anatomic extent alone is an insufficient predictor. A number of studies have shown that various histopathologic characteristics are individually predictive of survival, but few studies have attempted to use a combination of variables to predict survival. Our analysis incorporated individually predictive histologic characteristics into a logical extension of the AJCC anatomic staging system based on tumor biology. We found that a simple combination of readily available histopathologic characteristics reflecting aggressiveness of tumor biology (differentiation, local extrapancreatic extension, and lymphatic invasion within the tumor) predict survival after pancreatectomy. The value of staging patients in this way goes beyond being able to predict how long an individual patient will survive after pancreatectomy. Based on staging by histopathologic characteristics, select patients in whom long-term survival is expected may elect to avoid adjuvant therapy so as to be spared its adverse effects. Clinical trials assessing the benefits of new adjuvant therapy regimens need to consider patient histopathologic characteristics in study design and take into account any differences between study arms. As we come to better understand the biology of pancreatic cancer, future studies may show that molecular staging is of value in predicting survival after pancreatectomy for ductal adenocarcinoma. Conflict of Interest Disclosures Supported in part by the Analytic Microscopy Core Facility of the Moffitt Cancer Center. Funded in part by the Gastrointestinal Cancer Research Fund of the Moffitt Cancer Center. References 1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, CA Cancer J Clin. 2008;58: Helm J, Centeno BA, Coppola D, et al. Outcomes following resection of pancreatic adenocarcinoma: 20-year experience at a single institution. Cancer Control. 2008;15: Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6 th ed. New York: Springer-Verlag; 2002: Brennan MF, Kattan MW, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004;240: Ferrone CR, Kattan MW, Tomlinson JS, Thayer SP, Brennan MF, Warshaw AL. Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol. 2005;23: Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma. A population-based, linked database analysis of 396 patients. Ann Surg. 2003;237: Winter JM, Cameron JL, Campbell KA, et al Pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg. 2006;10: Benassai G, Mastrorilli M, Quarto G, et al. Factors influencing survival after resection for ductal adenocaracinoma of the head of the pancreas. J Surg Oncol. 2000;73: Magistrelli P, Antinori A, Crucitti A, et al. Prognostic factors after surgical resection for pancreatic carcinoma. J Surg Oncol. 2000;74: Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg. 2003;27: Moon HJ, An JY, Heo JS, Choi SH, Joh JW, Kim YI. Predicting survival after surgical resection for pancreatic ductal adenocarcinoma. Pancreas. 2006;32: Cancer September 15, 2009
10 Survival After Pancreatectomy for Cancer/Helm et al 12. Cress RD, Yin D, Clarke L, Bold R, Holly EA. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States). Cancer Causes Control. 2006;17: Raut CP, Tseng JF, Sun CC, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg. 2007;246: Schnelldorfer T, Ware AL, Sarr MG, et al. Long-term survival after pancreatectomy for pancreatic adenocarcinoma. Is cure possible? Ann Surg. 2008;247: Salvia R, Fernandez-del Castillo C, Bassi C, et al. Mainduct intraductal papillary mucinous neoplasms of the pancreas. Clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004;239: Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas. An updated experience. Ann Surg. 2004;239: Slidell MB, Chang DC, Cameron JL, et al. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol. 2008;15: Mitsunaga S, Hasebe T, Iwasaki M, Kinoshita T, Ochiai A, Shimizu N. Important prognostic histological parameters for patients with invasive ductal carcinoma of the pancreas. Cancer Sci. 2006;96: Meyer W, Jurowich C, Reichel M, Steinhauser B, Wunsch PH, Gebhardt C. Patholomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas. Surg Today. 2000;30: Sohn T, Yeo CL, Cameron JL, et al. Resected adenocarcinoma of the pancreas 616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000;4: Gebhardt C, Meyer W, Reichel M, Wunsch PH. Prognostic factors in the operative treatment of ductal pancreatic carcinoma. Langenbeck s Arch Surg. 2000;385: Fritz A, Percy C, Jack A, et al, eds. International Classification of Diseases for Oncology, 3 rd ed. Geneva, Switzerland: World Health Organization; Beger HG, Rau B, Gansauge F, Poch B, Link K. Treatment of pancreatic cancer: challenge of the facts. World J Surg. 2003;27: Cancer September 15,
Surgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study
Original article Annals of Gastroenterology (2013) 26, 346-352 Surgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study Subhankar Chakraborty
More informationDoes the Mechanism of Lymph Node Invasion Affect Survival in Patients with Pancreatic Ductal Adenocarcinoma?
Does the Mechanism of Lymph Node Invasion Affect Survival in Patients with Pancreatic Ductal Adenocarcinoma? The Harvard community has made this article openly available. Please share how this access benefits
More informationOutcomes of adjuvant radiotherapy and lymph node resection in elderly patients with pancreatic cancer treated with surgery and chemotherapy
Original Article Outcomes of adjuvant radiotherapy and lymph node resection in elderly patients with pancreatic cancer treated with surgery and chemotherapy Jessica Frakes 1, Eric A. Mellon 1, Gregory
More informationIs Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer?
Is Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer? Lee H, Park JY, Youn S, Kwon W, Heo JS, Choi SH, Choi DW Department of Surgery, Samsung Medical Center Sungkyunkwan
More informationSivesh K. Kamarajah, BMedSci 1, William R. Burns, MD 2, Timothy L. Frankel, MD 2, Clifford S. Cho, MD 2, and Hari Nathan, MD, PhD 2
Ann Surg Oncol (2017) 24:2023 2030 DOI 10.1245/s10434-017-5810-x ORIGINAL ARTICLE HEPATOBILIARY TUMORS Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients
More informationPeritoneal Involvement in Stage II Colon Cancer
Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.
More informationPancreatic Ductal Adenocarcinoma: Long-Term Survival Does Not Equal Cure
Pancreatic Ductal Adenocarcinoma: Long-Term Survival Does Not Equal Cure The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation
More informationSurgical Management of Pancreatic Cancer
I Congresso de Oncologia D Or July 5-6, 2013 Surgical Management of Pancreatic Cancer Michael A. Choti, MD, MBA, FACS Department of Surgery Johns Hopkins University School of Medicine, Baltimore, MD Estimated
More informationThe role of hepatic artery lymph node in pancreatic adenocarcinoma: prognostic factor or a selection criterion for surgery
DOI:10.1111/hpb.12306 HPB ORIGINAL ARTICLE The role of hepatic artery lymph node in pancreatic adenocarcinoma: prognostic factor or a selection criterion for surgery Prejesh Philips, Erik Dunki-Jacobs,
More informationPancreatic intraglandular metastasis predicts poorer outcome in postoperative patients with pancreatic
Pancreatic intraglandular metastasis predicts poorer outcome in postoperative patients with pancreatic ductal carcinoma Seiji Oguro, MD * +, Kazuaki Shimada, MD, PhD, Yoshinori Ino, PhD *, Minoru Esaki,
More informationIs it Time to Stop Checking Frozen Section Neck Margins During Pancreaticoduodenectomy?
Ann Surg Oncol (2013) 20:3626 3633 DOI 10.1245/s10434-013-3080-9 ORIGINAL ARTICLE PANCREATIC TUMORS Is it Time to Stop Checking Frozen Section Neck Margins During Pancreaticoduodenectomy? Neha L. Lad,
More informationPANCREATECTOMY WITH MESENTERIC AND PORTAL VEIN RESECTION FOR BORDERLINE RESECTABLE PANCREATIC CANCER: MULTICENTER STUDY
PROPOSAL: PANCREATECTOMY WITH MESENTERIC AND PORTAL VEIN RESECTION FOR BORDERLINE RESECTABLE PANCREATIC CANCER: MULTICENTER STUDY Pancreatic carcinoma represents the fourth-leading cause of cancer-related
More informationClinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients
Yonago Acta medica 2012;55:57 61 Clinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients Hiroaki Saito, Seigo Takaya, Yoji Fukumoto, Tomohiro Osaki, Shigeru Tatebe and Masahide
More informationPancreas (Exocrine) Protocol applies to all carcinomas of the exocrine pancreas.
Pancreas (Exocrine) Protocol applies to all carcinomas of the exocrine pancreas. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition Procedures Cytology (No Accompanying Checklist)
More informationPatient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival
MOLECULAR AND CLINICAL ONCOLOGY 7: 1083-1088, 2017 Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival FARUK TAS
More informationPrognostic Significance of Grading and Staging Systems using MIB-1 Score in Adult Patients with Soft Tissue Sarcoma of the Extremities and Trunk
843 Prognostic Significance of Grading and Staging Systems using MIB-1 Score in Adult Patients with Soft Tissue Sarcoma of the Extremities and Trunk Tadashi Hasegawa, M.D. 1 Seiichiro Yamamoto, Ph.D. 2
More informationOnly Estrogen receptor positive is not enough to predict the prognosis of breast cancer
Young Investigator Award, Global Breast Cancer Conference 2018 Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer ㅑ Running head: Revisiting estrogen positive tumors
More informationConditional survival in pancreatic cancer: better than expected
DOI:10.1111/j.1477-2574.2011.00379.x HPB ORIGINAL ARTICLE Conditional survival in pancreatic cancer: better than expected Tara S. Kent, Teviah E. Sachs, Norberto Sanchez, Charles M. Vollmer Jr & Mark P.
More informationGreater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14
Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14 Contents 14. Neuroendocrine Tumours 161 14.1. Diagnostic algorithm
More informationPredictive factors for invasive intraductal papillary mucinous neoplasm of the pancreas
Korean J Hepatobiliary Pancreat Surg 2011;15:27-22 Original Article Predictive factors for invasive intraductal papillary mucinous neoplasm of the pancreas Dae Young Jun 1, Hyung Jun Kwon 2, Sang Geol
More informationResearch Article Clinical Features and Outcomes Differ between Skeletal and Extraskeletal Osteosarcoma
Sarcoma, Article ID 902620, 8 pages http://dx.doi.org/10.1155/2014/902620 Research Article Clinical Features and Outcomes Differ between and Osteosarcoma Sheila Thampi, 1 Katherine K. Matthay, 1 W. John
More informationTopics: Staging and treatment for pancreatic cancer. Staging systems for pancreatic cancer: Differences between the Japanese and UICC systems
M. J Hep Kobari Bil Pancr and S. Surg Matsuno: (1998) Staging 5:121 127 system for pancreatic cancer 121 Topics: Staging and treatment for pancreatic cancer Staging systems for pancreatic cancer: Differences
More informationPAPER. Experience With 208 Resections for Intraductal Papillary Mucinous Neoplasm of the Pancreas
PAPER Experience With 0 Resections for Intraductal Papillary Mucinous Neoplasm of the Pancreas Thomas Schnelldorfer, MD; Michael G. Sarr, MD; David M. Nagorney, MD; Lizhi Zhang, MD; Thomas C. Smyrk, MD;
More informationLymph node ratio as a prognostic factor in stage III colon cancer
Lymph node ratio as a prognostic factor in stage III colon cancer Emad Sadaka, Alaa Maria and Mohamed El-Shebiney. Clinical Oncology department, Faculty of Medicine, Tanta University, Egypt alaamaria1@hotmail.com
More informationDifferential lymph node retrieval in rectal cancer: associated factors and effect on survival
Original Article Differential lymph node retrieval in rectal cancer: associated factors and effect on survival Cedrek McFadden 1, Brian McKinley 1, Brian Greenwell 2, Kaylee Knuckolls 1, Patrick Culumovic
More informationSurgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database
Surgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database Hadi Khan, MD 1, Adam J. Olszewski, MD 2 and Ponnandai S. Somasundar, MD 1 1 Department
More informationRevisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis
Jpn J Clin Oncol 1997;27(5)305 309 Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis -, -, - - 1 Chest Department and 2 Section of Thoracic Surgery,
More informationRadiotherapy and Conservative Surgery For Merkel Cell Carcinoma - The British Columbia Cancer Agency Experience
Radiotherapy and Conservative Surgery For Merkel Cell Carcinoma - The British Columbia Cancer Agency Experience Poster No.: RO-0003 Congress: RANZCR FRO 2012 Type: Scientific Exhibit Authors: C. Harrington,
More informationTemporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008
Special Report Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008 Matthew B. Schabath, PhD, Zachary J. Thompson, PhD,
More informationMarcel Th. M. van Rens, MD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans R. J. Elbers, MD, PhD; and Jules M. M. van den Bosch, MD, PhD, FCCP
Prognostic Assessment of 2,361 Patients Who Underwent Pulmonary Resection for Non-small Cell Lung Cancer, Stage I, II, and IIIA* Marcel Th. M. van Rens, MD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans
More informationAfter primary tumor treatment, 30% of patients with malignant
ESTS METASTASECTOMY SUPPLEMENT Alberto Oliaro, MD, Pier L. Filosso, MD, Maria C. Bruna, MD, Claudio Mossetti, MD, and Enrico Ruffini, MD Abstract: After primary tumor treatment, 30% of patients with malignant
More informationORIGINAL ARTICLE. Predicting the Prognosis of Oral Squamous Cell Carcinoma After First Recurrence
ORIGINAL ARTICLE Predicting the Prognosis of Oral Squamous Cell Carcinoma After First Recurrence Michael D. Kernohan, FDSRCS, FRCS, MSc; Jonathan R. Clark, FRACS; Kan Gao, BEng; Ardalan Ebrahimi, FRACS;
More informationORIGINAL ARTICLE. Fate of the Pancreatic Remnant After Resection for an Intraductal Papillary Mucinous Neoplasm
ONLINE FIRST ORIGINAL ARTICLE Fate of the Pancreatic Remnant After Resection for an Intraductal Papillary Mucinous Neoplasm A Longitudinal Level II Cohort Study Toshiyuki Moriya, MD, PhD; L. William Traverso,
More informationTreatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy
Korean J Hepatobiliary Pancreat Surg 2011;15:152-156 Original Article Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy Suzy Kim 1,#, Kyubo
More informationPrognostic value of visceral pleura invasion in non-small cell lung cancer q
European Journal of Cardio-thoracic Surgery 23 (2003) 865 869 www.elsevier.com/locate/ejcts Prognostic value of visceral pleura invasion in non-small cell lung cancer q Jeong-Han Kang, Kil Dong Kim, Kyung
More informationDesmoplastic Melanoma: Surgical Management and Adjuvant Therapy
Desmoplastic Melanoma: Surgical Management and Adjuvant Therapy Dale Han, MD Assistant Professor Department of Surgery Section of Surgical Oncology No disclosures Background Desmoplastic melanoma (DM)
More informationWHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER?
CANCER STAGING TNM and prognosis in CRC WHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER? Alessandro Lugli, MD Institute of Pathology University of Bern Switzerland Maastricht, June 19
More informationMeasure Specifications Measure Description
CMS ID/CMS QCDR ID: CAP 25 Title: Time for Pancreas Specifications Description Percentage of all eligible pancreatic exocrine carcinoma (including small cell and large cell (poorly differentiated) neuroendocrine
More informationESD for EGC with undifferentiated histology
ESD for EGC with undifferentiated histology Jun Haeng Lee, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Biopsy: M/D adenocarcinoma ESD: SRC >>
More informationCorrelation of tumor size and survival in pancreatic cancer
Original Article (Management of Foregut Malignancies and Hepatobiliary Tract and Pancreas Malignancies) Correlation of tumor size and survival in pancreatic cancer Caitlin Takahashi 1, Ravi Shridhar 2,
More informationEnrollment Form: Pancreas
Tissue Source Site (TSS) Name: TSS Identifier: _ TSS Unique Patient #: Completed By: Completion Date (MM/DD/YYYY): Form Notes: An Enrollment Form should be completed for each TCGA qualified case upon qualification
More informationPoor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas
10 The Open Otorhinolaryngology Journal, 2011, 5, 10-14 Open Access Poor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas Kevin C. Huoh and Steven J. Wang * Head and Neck Surgery and Oncology,
More informationPancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts)
Pancreas Quizzes Quiz 1 1. The pancreas produces hormones. Which type of hormone producing organ is the pancreas? a. Endocrine b. Exocrine c. Both A and B d. Neither A or B 2. Endocrine indicates hormones
More informationORIGINAL ARTICLE HEPATOBILIARY TUMORS. Ann Surg Oncol (2012) 19: DOI /s
Ann Surg Oncol (2012) 19:1316 1323 DOI 10.1245/s10434-011-2088-2 ORIGINAL ARTICLE HEPATOBILIARY TUMORS Adjuvant Radiotherapy in the Treatment of Invasive Intraductal Papillary Mucinous Neoplasm of the
More informationOutcomes of pancreaticoduodenectomy in patients with metastatic cancer
Korean J Hepatobiliary Pancreat Surg 2014;18:147-151 http://dx.doi.org/.14701/kjhbps.2014.18.4.147 Original Article Outcomes of pancreaticoduodenectomy in patients with metastatic cancer Joo Hwa Kwak,
More informationNatural History and Treatment Trends in Hepatocellular Carcinoma Subtypes: Insights From a National Cancer Registry
2015;112:872 876 Natural History and Treatment Trends in Hepatocellular Carcinoma Subtypes: Insights From a National Cancer Registry PETER L. JERNIGAN, MD, KOFFI WIMA, MS, DENNIS J. HANSEMAN, PhD, RICHARD
More informationClinical analysis of 29 cases of nasal mucosal malignant melanoma
1166 Clinical analysis of 29 cases of nasal mucosal malignant melanoma HUANXIN YU and GANG LIU Department of Otorhinolaryngology Head and Neck Surgery, Tianjin Huanhu Hospital, Tianjin 300060, P.R. China
More informationObjectives. Intraoperative Consultation of the Whipple Resection Specimen. Pancreas Anatomy. Pancreatic ductal carcinoma 11/10/2014
Intraoperative Consultation of the Whipple Resection Specimen Pathology Update Faculty of Medicine, University of Toronto November 15, 2014 John W. Wong, MD, FRCPC Department of Anatomical Pathology Sunnybrook
More informationDisclosures. Outline. What IS tumor budding?? Tumor Budding in Colorectal Carcinoma: What, Why, and How. I have nothing to disclose
Tumor Budding in Colorectal Carcinoma: What, Why, and How Disclosures I have nothing to disclose Soo-Jin Cho, MD, PhD Assistant Professor UCSF Dept of Pathology Current Issues in Anatomic Pathology 2017
More informationPrognostic factors in curatively resected pathological stage I lung adenocarcinoma
Original Article Prognostic factors in curatively resected pathological stage I lung adenocarcinoma Yikun Yang 1, Yousheng Mao 1, Lin Yang 2, Jie He 1, Shugeng Gao 1, Juwei Mu 1, Qi Xue 1, Dali Wang 1,
More informationAlthough the international TNM classification system
Prognostic Significance of Perioperative Serum Carcinoembryonic Antigen in Non-Small Cell Lung Cancer: Analysis of 1,000 Consecutive Resections for Clinical Stage I Disease Morihito Okada, MD, PhD, Wataru
More informationTalk to Your Doctor. Fact Sheet
Talk to Your Doctor Hearing the words you have skin cancer is overwhelming and would leave anyone with a lot of questions. If you have been diagnosed with Stage I or II cutaneous melanoma with no apparent
More informationPredictors in Determining Recurrence of Pancreatic Cancer
Predictors in Determining Recurrence of Pancreatic Cancer Lesly Almanzar Kean University Reed Johnson Luther College Alexandria Leonhardt Cornell College Evelyn Rodriguez Correa Pontifical Catholic University
More informationA Multicentric Development Of Intraductal Papillary Mucinous Neoplasm Treated By Repeated Pancreatectomy
ISPUB.COM The Internet Journal of Surgery Volume 7 Number 2 A Multicentric Development Of Intraductal Papillary Mucinous Neoplasm Treated By Repeated T Matsumoto, K Iwaki, H Uchida, K Yada, K Shibata,
More informationPerigastric lymph node metastases in gastric cancer: comparison of different staging systems
Gastric Cancer (1999) 2: 201 205 Original article 1999 by International and Japanese Gastric Cancer Associations Perigastric lymph node metastases in gastric cancer: comparison of different staging systems
More informationOutcomes associated with robotic approach to pancreatic resections
Short Communication (Management of Foregut Malignancies and Hepatobiliary Tract and Pancreas Malignancies) Outcomes associated with robotic approach to pancreatic resections Caitlin Takahashi 1, Ravi Shridhar
More informationEthnic Disparities in the Treatment of Stage I Non-small Cell Lung Cancer. Juan P. Wisnivesky, MD, MPH, Thomas McGinn, MD, MPH, Claudia Henschke, PhD,
Ethnic Disparities in the Treatment of Stage I Non-small Cell Lung Cancer Juan P. Wisnivesky, MD, MPH, Thomas McGinn, MD, MPH, Claudia Henschke, PhD, MD, Paul Hebert, PhD, Michael C. Iannuzzi, MD, and
More informationImpact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: implications for adjuvant radiotherapy
Original Article Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: implications for adjuvant radiotherapy Arsen Osipov 1, Jason Naziri 2, Andrew Hendifar
More informationPrognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer
Hou et al. World Journal of Surgical Oncology (2018) 16:198 https://doi.org/10.1186/s12957-018-1504-5 REVIEW Open Access Prognostic significance of metastatic lymph node ratio: the lymph node ratio could
More informationRisk Factors and Tumor Recurrence in pt1n0m0 Gastric Cancer after Surgical Treatment
pissn : 293-582X, eissn : 293-5641 J Gastric Cancer 216;16(4):215-22 https://doi.org/1.523/jgc.216.16.4.215 Original Article Risk Factors and Tumor Recurrence in pt1nm Gastric Cancer after Surgical Treatment
More informationThe Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non Small-Cell Lung Cancer
Original Article The Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non Small-Cell Lung Cancer Chen Qiu, MD,* Wei Dong, MD,* Benhua Su, MBBS, Qi Liu, MD,* and Jiajun Du, PhD Introduction:
More informationResearch Article Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy
International Surgical Oncology Volume 2012, Article ID 307670, 7 pages doi:10.1155/2012/307670 Research Article Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy
More informationAnalysis of the outcome of young age tongue squamous cell carcinoma
Jeon et al. Maxillofacial Plastic and Reconstructive Surgery (2017) 39:41 DOI 10.1186/s40902-017-0139-8 Maxillofacial Plastic and Reconstructive Surgery RESEARCH Open Access Analysis of the outcome of
More informationRadical nerve dissection for the carcinoma of head of pancreas: report of 30 cases
Original Article Radical nerve dissection for the carcinoma of head of pancreas: report of 30 cases Qing Lin, Langping Tan, Yu Zhou, Quanbo Zhou, Rufu Chen Department of Biliary and Pancreatic Surgery,
More informationTumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma
ONCOLOGY LETTERS 9: 125-130, 2015 Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma KEIICHI ITO 1, KENJI SEGUCHI 1, HIDEYUKI SHIMAZAKI 2, EIJI TAKAHASHI
More informationClinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma
Original Article Clinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma Zhaode Bu, Zhixue Zheng, Ziyu Li, Xiaojiang Wu, Lianhai Zhang, Aiwen Wu,
More informationPrognostic factors associated with early mortality after surgical resection for pancreatic adenocarcinoma
Korean J Hepatobiliary Pancreat Surg 04;8:38-46 http://dx.doi.org/0.470/kjhbps.04.8.4.38 Original Article Prognostic factors associated with early mortality after surgical resection for pancreatic adenocarcinoma
More informationLung cancer pleural invasion was recognized as a poor prognostic
Visceral pleural invasion classification in non small cell lung cancer: A proposal on the basis of outcome assessment Kimihiro Shimizu, MD a Junji Yoshida, MD a Kanji Nagai, MD a Mitsuyo Nishimura, MD
More informationIndeterminate Pulmonary Nodules in Patients with Colorectal Cancer
Indeterminate Pulmonary Nodules in Patients with Colorectal Cancer Jai Sule 1, Kah Wai Cheong 2, Stella Bee 2, Bettina Lieske 2,3 1 Dept of Cardiothoracic and Vascular Surgery, University Surgical Cluster,
More informationPrognostic value of the 8 th tumor-node-metastasis classification for follicular carcinoma and poorly differentiated carcinoma of the thyroid in Japan
2018, 65 (6), 621-627 ORIGINAL Prognostic value of the 8 th tumor-node-metastasis classification for follicular carcinoma and poorly differentiated carcinoma of the thyroid in Japan Yasuhiro Ito 1), Akira
More informationRebecca Vogel, PGY-4 March 5, 2012
Rebecca Vogel, PGY-4 March 5, 2012 Historical Perspective Changes In The Staging System Studies That Started The Talk Where We Go From Here Cutaneous melanoma has become an increasingly growing problem,
More informationSurvival Comparison of Adenosquamous, Squamous Cell, and Adenocarcinoma of the Lung After Lobectomy
Survival Comparison of Adenosquamous, Squamous Cell, and Adenocarcinoma of the Lung After Lobectomy David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L. Chen, MD, MBA, Cindy Yu, MD, and Royce
More informationSatisfactory surgical outcome of T2 gastric cancer after modified D2 lymphadenectomy
Original Article Satisfactory surgical outcome of T2 gastric cancer after modified D2 lymphadenectomy Shupeng Zhang 1, Liangliang Wu 2, Xiaona Wang 2, Xuewei Ding 2, Han Liang 2 1 Department of General
More informationAndrogen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target?
Androgen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target? New Frontiers in Urologic Oncology Juan Chipollini, MD Clinical Fellow Department of Genitourinary Oncology Moffitt Cancer
More informationClinical Study Mucosal Melanoma in the Head and Neck Region: Different Clinical Features and Same Outcome to Cutaneous Melanoma
ISRN Dermatology Volume 2013, Article ID 586915, 5 pages http://dx.doi.org/10.1155/2013/586915 Clinical Study Mucosal Melanoma in the Head and Neck Region: Different Clinical Features and Same Outcome
More informationTreatment of oligometastatic NSCLC
Treatment of oligometastatic NSCLC Jarosław Kużdżał Department of Thoracic Surgery Jagiellonian University Collegium Medicum, John Paul II Hospital, Cracow New idea? 14 NSCLC patients with solitary extrathoracic
More informationPancreatobiliary Frozen Section Nightmares
Pancreatobiliary Frozen Section Nightmares Aatur D. Singhi, MD PhD Assistant Professor University of Pittsburgh Medical Center Department of Pathology singhiad@upmc.edu Objectives Briefly give an overview
More informationORIGINAL ARTICLE. Clinical Node-Negative Thick Melanoma
ORIGINAL ARTICLE Clinical Node-Negative Thick Melanoma George I. Salti, MD; Ashwin Kansagra, MD; Michael A. Warso, MD; Salve G. Ronan, MD ; Tapas K. Das Gupta, MD, PhD, DSc Background: Patients with T4
More informationPrognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai, China
www.springerlink.com Chin J Cancer Res 23(4):265 270, 2011 265 Original Article Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai,
More informationCharacteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Characteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases Mei Li & Zhi-xiong Lin Department of Radiation
More informationTranslating Evidence into Practice: Primary Cutaneous Melanoma Guidelines. Sentinel Lymph Node Biopsy
American Academy of Dermatology 2018 Annual Meeting San Diego, CA, February 17, 2018 Translating Evidence into Practice: Primary Cutaneous Melanoma Guidelines. Sentinel Lymph Node Biopsy Christopher Bichakjian,
More informationGastric Cancer Histopathology Reporting Proforma
Gastric Cancer Histopathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.01). S1.01 Identification Family name Given name(s) Date of birth Sex Male Female Intersex/indeterminate
More informationA Selective Approach to Resection of Cystic Lesions of the Pancreas: Results From 539 Consecutive Patients
LETTER TO THE EDITOR A Selective Approach to Resection of Cystic Lesions of the Pancreas: Results From 539 Consecutive Patients To the Editor: I would like to congratulate Dr. Allen and colleagues for
More informationRESEARCH ARTICLE. Normalization of CA19-9 Following Resection for Pancreatic Ductal Adenocarcinoma is not Tantamount to being Cured?
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.2.661 Normalization of CA19-9 Following Resection for Pancreatic Ductal Adenocarcinoma is not Tantamount to being Cured? RESEARCH ARTICLE Normalization of CA19-9
More informationSupplementary Information
Supplementary Information Prognostic Impact of Signet Ring Cell Type in Node Negative Gastric Cancer Pengfei Kong1,4,Ruiyan Wu1,Chenlu Yang1,3,Jianjun Liu1,2,Shangxiang Chen1,2, Xuechao Liu1,2, Minting
More informationModified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast
British Journal of Cancer (2011) 105, 698 708 All rights reserved 0007 0920/11 www.bjcancer.com Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma
More informationChange in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer
Original Article Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer Gary Y. Yang 1, Nadia K. Malik 2, Rameela Chandrasekhar
More informationThe Predictors and Clinical Impact of Positive Resection Margins on Frozen Section in Gastric Cancer Surgery
J Gastric Cancer 2012;12(2):113-119 http://dx.doi.org/10.5230/jgc.2012.12.2.113 Original Article The Predictors and Clinical Impact of Positive Resection Margins on Frozen Section in Gastric Cancer Surgery
More informationNumber of Metastatic Lymph Nodes in Resected Non Small Cell Lung Cancer Predicts Patient Survival
Number of Metastatic Lymph Nodes in Resected Non Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD, Dae Joon Kim, MD, Seong Yong Park, MD, Kil Dong Kim,
More informationNeoplasias Quisticas del Páncreas
SEAP -Aproximación Práctica a la Patología Gastrointestinal- Madrid, 26 de mayo, 2006 Neoplasias Quisticas del Páncreas Gregory Y. Lauwers, M.D. Director, Service Massachusetts General Hospital Harvard
More informationIntended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with pancreatic
Intended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with pancreatic cancer Section AA Cancer Centre Referrals In the absence of metastatic
More informationLower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance
Original Article Lower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance Dedrick Kok Hong Chan 1,2, Ker-Kan Tan 1,2 1 Division of Colorectal Surgery, University
More informationSurvival Prediction Models for Estimating the Benefit of Post-Operative Radiation Therapy for Gallbladder Cancer and Lung Cancer
Survival Prediction Models for Estimating the Benefit of Post-Operative Radiation Therapy for Gallbladder Cancer and Lung Cancer Jayashree Kalpathy-Cramer PhD 1, William Hersh, MD 1, Jong Song Kim, PhD
More informationcategory cm0. Category will ensure it T1 melanoma. 68 Retinoblastoma
AJCC 8 th Edition Chapter 1 Principles of Cancer Staging: Node Status Not Required in Rare Circumstances Clinical Staging, cn Category For some cancer sites in which lymph node involvement is rare, patients
More informationIntroduction ORIGINAL RESEARCH
Cancer Medicine ORIGINAL RESEARCH Open Access The effect of radiation therapy in the treatment of adult soft tissue sarcomas of the extremities: a long- term community- based cancer center experience Jeffrey
More informationPancreatic Cancer. BIOLOGY: Not well defined (genetic and enviromental factors) CLINICAL PRESENTATION: Abd pain, jaundice, weight loss.
EloreMed Editor: Le Wang, MD, PhD Date of Update: 2/6/2018 UpToDate: Liposomal irinotecan (Onivyde) plus FU/LV is now approved for gemcitabine-refractory metastatic pancreatic cancer and recommended by
More informationLog odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection
Original Article Log odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection Mingjian Yang 1,2, Hongdian Zhang 1,2, Zhao Ma 1,2, Lei Gong 1,2, Chuangui Chen
More informationLung cancer is a major cause of cancer deaths worldwide.
ORIGINAL ARTICLE Prognostic Factors in 3315 Completely Resected Cases of Clinical Stage I Non-small Cell Lung Cancer in Japan Teruaki Koike, MD,* Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, Yasunori Sohara,
More informationThis form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More informationImpact of Screening Colonoscopy on Outcomes in Colon Cancer Surgery
Impact of Screening Colonoscopy on Outcomes in Colon Cancer Surgery The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation
More information